Apicad Pharmaceuticals Private Limited
About Apicad Pharmaceuticals Private Limited
Data last updated:
Apicad Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 30 December 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2009PTC197391.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santosh Kumar Singh and Mohan Rakesh.
Its last annual general meeting (AGM) was held on 29 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Plot No – 121B Second Floor Gali No – 6 Vipin Garden Extension Uttam Nagar, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2017, the company reported a revenue of ₹13.07 Lakh. For the same year it recorded a net profit of ₹9,762 (net margin 0.7%) and EBITDA of ₹3.15 Lakh (EBITDA margin 24.1%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Apicad Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No – 121B Second Floor Gali No – 6 Vipin Garden Extension Uttam Nagar, New Delhi, Delhi, India – 110059
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Apicad Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Apicad Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Apicad Pharmaceuticals Private Limited
FY 2021 filings availableApicad Pharmaceuticals Private Limited reported revenue of ₹13.07 Lakh for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹13.07 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹3.15 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹9,762 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 24.1% | ||
| Net Profit Margin | 0.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Apicad Pharmaceuticals Private Limited, buy the company report.
Board of directors of Apicad Pharmaceuticals Private Limited
Apicad Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Kumar Singh | Director | 24 Aug 2020 | 6 Years 2 Months | Current |
| Mohan Rakesh | Director | 30 Dec 2009 | 16 Years 10 Months | Current |
Auditor
Apicad Pharmaceuticals Private Limited is audited by NAND JEE & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NAND JEE & CO | FY 2017 | 017531N |
Shareholding
The shareholding of Apicad Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Apicad Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Apicad Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Apicad Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Apicad Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Apicad Pharmaceuticals Private Limited has 8 board changes on record since 2009: 2 appointments and 6 cessations. The latest: Ranjay Kumar Thakur ceased to be Director on 08 Sep 2020.
Frequently asked questions
Apicad Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 30 December 2009 (17+ years old) and is registered under CIN U24230DL2009PTC197391.
Apicad Pharmaceuticals has 2 current directors:
- Santosh Kumar Singh - Director
- Mohan Rakesh - Director
The latest financial statements of Apicad Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 29 November 2021. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Apicad Pharmaceuticals is U24230DL2009PTC197391. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apicad Pharmaceuticals was incorporated on 30 December 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
Ranjay Kumar Thakur ceased to be Director on 08 Sep 2020. Ranjay Kumar Thakur ceased to be Director on 08 Sep 2020. Sanjay Kumar ceased to be Director on 08 Sep 2020. Apicad Pharmaceuticals has 8 board changes on record in total.
The registered office of Apicad Pharmaceuticals is at Plot No – 121B Second Floor Gali No – 6 Vipin Garden Extension Uttam Nagar, New Delhi, Delhi, India – 110059.
Apicad Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Apicad Pharmaceuticals is compliant as of 28 September 2026. The company is actively filing with the Registrar of Companies.
Apicad Pharmaceuticals can be reached at its registered office: Plot No – 121B Second Floor Gali No – 6 Vipin Garden Extension Uttam Nagar, New Delhi, Delhi, India – 110059.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
